Universal Health Realty Income Trust (UHT) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 23	—	$0.32	—	—	$23.2M	—
Q4 22	—	$0.41	—	—	$24.1M	—
Q3 22	—	$0.35	—	—	$22.2M	—
Q2 22	—	$0.38	—	—	$22.2M	—
Q1 22	—	$0.39	—	—	$22.2M	—
Q4 21	—	$0.41	—	—	$21.4M	—
Q3 21	—	$0.39	—	—	$21.2M	—
Q2 21	—	$0.39	—	—	$20.9M	—
Q1 21	—	$0.41	—	—	$20.7M	—
Q4 20	—	$0.36	—	—	$19.8M	—
Q3 20	—	$0.34	—	—	$19.7M	—
Q2 20	—	$0.34	—	—	$19.3M	—
Q1 20	—	$0.33	—	—	$19.2M	—
Q4 19	—	$0.3	—	—	$18.9M	—
Q3 19	—	$0.34	—	—	$19.9M	—
Q2 19	—	$0.31	—	—	$19.3M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$1.27	—	—	$99.2M	—
FY24	—	$1.39	—	—	$99M	—
FY23	—	$1.12	—	—	$95.6M	—
FY22	—	$1.53	—	—	$90.6M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$67.1M	$72.3M	$76.2M	$77.2M	$78M	$84.2M	$90.6M	$95.6M	$99M	$99.2M
YoY change	+4.9%	+7.85%	+5.34%	+1.25%	+1.1%	+7.92%	+7.64%	+5.46%	+3.6%	+0.18%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	67.1M	72.3M	76.2M	77.2M	78M	84.2M	90.6M	95.6M	99M	99.2M
Cost of revenue	3.3M	3.6M	3.8M	4M	4.1M	4.4M	5.1M	5.3M	5.5M	5.6M
Gross profit	63.8M	68.8M	72.4M	73.2M	73.9M	79.8M	85.5M	90.3M	93.5M	93.6M
Gross margin	95.1%	95.1%	95%	94.8%	94.7%	94.8%	94.4%	94.4%	94.5%	94.4%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	3.3M	3.6M	3.8M	4M	4.1M	—	—	—	—	—
Operating expenses	21.5M	23.1M	24.5M	25.5M	26.4M	23.4M	28.3M	31.2M	29.3M	30M
Operating income	22.6M	24.1M	26.7M	25.8M	26M	28.9M	30.7M	31.3M	36.8M	34.8M
Operating margin	33.8%	33.4%	35%	33.4%	33.3%	34.3%	33.8%	32.8%	37.2%	35%
Non-operating income, net	3.9M	31.5M	7.5M	3.7M	1.7M	89.1M	1.2M	975K	1.3M	1.7M
Pretax income	17.2M	45.6M	24.2M	19M	19.4M	109.2M	21.1M	15.4M	19.2M	17.6M
Income tax	—	—	—	—	—	—	—	—	—	—
Net income	17.2M	45.6M	24.2M	19M	19.4M	109.2M	21.1M	15.4M	19.2M	17.6M
Net margin	25.7%	63.1%	31.7%	24.6%	24.9%	129.7%	23.3%	16.1%	19.4%	17.8%
EBITDA	50.1M	78.9M	53.1M	53.4M	53.3M	58.1M	58.7M	65.4M	70.5M	67.6M
EPS	1.28	3.35	1.76	1.38	1.42	7.94	1.53	1.12	1.39	1.27
Diluted EPS	1.28	3.35	1.76	1.38	1.41	7.92	1.53	1.11	1.39	1.27

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	24.2M	24.3M	25.1M	24.7M	24.5M	24.6M	24.5M	24.9M	25.3M	24.5M	24.5M	25M
Cost of revenue	1.3M	1.4M	1.3M	1.4M	1.4M	1.4M	1.4M	1.4M	1.4M	1.4M	1.4M	1.4M
Gross profit	22.9M	23M	23.8M	23.4M	23.1M	23.3M	23.2M	23.5M	23.9M	23M	23.1M	23.6M
Gross margin	94.5%	94.4%	94.7%	94.5%	94.3%	94.4%	94.4%	94.4%	94.4%	94.2%	94.3%	94.3%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	—	—	—	—	—	—	—	—	—	—	—	—
Operating expenses	7.9M	7.5M	7.5M	7M	7.6M	7.2M	7.3M	7.6M	7.6M	7.4M	7.2M	7.3M
Operating income	8M	8.2M	9.5M	9.6M	8.5M	9.3M	9M	8.8M	8.4M	8.5M	9M	9.2M
Operating margin	33.1%	33.5%	37.6%	38.7%	34.7%	37.6%	36.8%	35.6%	33.2%	34.7%	36.5%	36.8%
Non-operating income, net	1.9M	-4.2M	2M	1.9M	1.8M	-4.5M	1.2M	1.1M	1.2M	-1.9M	1M	1.6M
Pretax income	3.9M	3.6M	5.3M	5.3M	4M	4.7M	4.8M	4.5M	4M	4.3M	5M	5.9M
Income tax	—	—	—	—	—	—	—	—	—	—	—	—
Net income	3.9M	3.6M	5.3M	5.3M	4M	4.7M	4.8M	4.5M	4M	4.3M	5M	5.9M
Net margin	16%	14.8%	21.1%	21.3%	16.3%	18.9%	19.5%	18.1%	15.9%	17.7%	20.5%	23.6%
EBITDA	15.2M	21.3M	16.5M	16.5M	15.6M	17.1M	16.1M	16M	16.5M	16.6M	16.3M	16.5M
EPS	0.28	—	0.38	0.38	0.29	0.34	0.35	0.33	0.29	0.31	0.36	0.43
Diluted EPS	0.28	—	0.38	0.38	0.29	0.34	0.34	0.32	0.29	0.31	0.36	0.43

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	883.1M	1B	842.1M	1.6B	883.3M	818.1M	657.3M	596.2M	513.6M	541.9M	539.1M
Enterprise value	1.2B	1.3B	1.1B	1.9B	1.2B	1.1B	1B	958.4M	885.6M	921.3M	922.9M
Shares outstanding	13.5M	13.6M	13.7M	13.7M	13.7M	13.8M	13.8M	13.8M	13.8M	13.8M	13.8M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	51.3	22.4	34.8	85	45.4	7.49	31.1	38.7	26.7	30.8	27.8
P/S	13.2	14.1	11	20.9	11.3	9.72	7.25	6.24	5.19	5.46	5.32
P/B	4.62	4.86	4.24	8.87	5.55	3.48	2.87	2.97	2.86	3.56	3.74
EV/EBITDA	23.8	16.2	20.7	35.3	22.2	19.5	17.1	14.7	12.6	13.6	14
EV/Sales	17.8	17.6	14.4	24.5	15.1	13.5	11.1	10	8.94	9.29	9.12
Earnings yield	1.95%	4.46%	2.87%	1.18%	2.2%	13.3%	3.21%	2.58%	3.75%	3.25%	3.59%
FCF yield	-2.23%	3.61%	4.62%	2.33%	4.75%	4.25%	5.05%	5.92%	9.13%	9.06%	8.54%
PEG	—	—	—	—	—	—	—	—	—	—	0.92

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	95.1%	95.1%	95%	94.8%	94.7%	94.8%	94.4%	94.4%	94.5%	94.4%	94.3%
Operating margin	33.8%	33.4%	35%	33.4%	33.3%	34.3%	33.8%	32.8%	37.2%	35%	37.9%
Net margin	25.7%	63.1%	31.7%	24.6%	24.9%	129.7%	23.3%	16.1%	19.4%	17.8%	19%
ROE	9%	21.7%	12.2%	10.4%	12.2%	46.4%	9.21%	7.66%	10.7%	11.6%	12.5%
ROA	3.28%	9.31%	5%	3.88%	3.94%	18.2%	3.47%	2.58%	3.31%	3.12%	4.15%
Return on tangible assets	3.61%	10.2%	5.39%	4.13%	4.13%	18.9%	3.53%	2.62%	3.35%	3.15%	3.43%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.05	0.06	0.07	0.07	0.06	0.41	0.34	0.31	0.29	0.28	7.37
Quick ratio	0.05	0.06	0.07	0.07	0.06	0.41	0.34	0.31	0.29	0.28	0.27
Debt / equity	1.65	1.22	1.32	1.56	1.91	1.45	1.55	1.84	2.11	2.53	2.75
Debt / assets	0.6	0.52	0.54	0.58	0.62	0.57	0.58	0.62	0.65	0.68	0.7
Net debt / EBITDA	6.22	3.21	4.82	5.18	5.6	5.47	5.9	5.54	5.28	5.61	5.89
Interest coverage	2.84	5.53	3.5	2.8	3.35	13.4	2.91	1.7	1.81	1.83	1.96

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	4.98	5.31	5.55	5.62	5.68	6.12	6.58	6.93	7.17	7.18	7.31
EPS (basic)	1.28	3.35	1.76	1.38	1.42	7.94	1.53	1.12	1.39	1.27	1.27
EPS (diluted)	1.28	3.35	1.76	1.38	1.41	7.92	1.53	1.11	1.39	1.27	1.39
Book value per share	14.2	15.5	14.5	13.2	11.6	17.1	16.6	14.6	13	11	10.4
FCF per share	-1.46	2.71	2.83	2.73	3.05	2.52	2.41	2.56	3.4	3.55	3.47
Cash per share	0.29	0.25	0.37	0.44	0.42	1.64	0.55	0.6	0.51	0.48	0.68
Capex per share	4.49	0.66	0.3	0.17	0.16	1.1	0.99	0.27	—	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	90%	12.5%	5.32%	3.03%	2.9%	18%	15%	3.9%	—	—	—
Capex / operating cash flow	148.7%	12.4%	9.24%	5.29%	5.1%	11.2%	29.8%	8.68%	—	—	—
Payout ratio	204.1%	79%	152.2%	197.3%	195.3%	35.3%	185.7%	258.2%	210%	233%	214.4%
Dividend yield	3.98%	3.52%	4.37%	2.32%	4.3%	4.71%	5.96%	6.67%	7.87%	7.57%	7.73%

Yield

7.73%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.75

ex-dividend Jun 22, 2026

Payout ratio

214%

of earnings

Dividend growth

11 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jun 22, 2026	$0.75
Mar 23, 2026	$0.745
Dec 22, 2025	$0.745

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$24.2M	$24.3M	$25.1M	$24.7M	$24.5M	$24.6M	$24.5M	$24.9M	$25.3M	$24.5M	$24.5M	$25M
YoY change	+9.35%	+0.8%	+8.25%	+3.9%	+1.12%	+1.32%	-2.36%	+0.54%	+3.3%	-0.69%	-0.08%	+0.49%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	3.9M	3.4M	5M	6.1M	5.7M	22.5M	7.6M	8.2M	7.1M	6.7M
Receivables	7.6M	9.1M	10.2M	10.6M	10.7M	11.8M	13.8M	14.3M	15.1M	15.6M
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	11.5M	12.5M	15.2M	16.7M	16.4M	116.7M	105M	105.8M	105M	104.4M
Property, plant & equipment	-87M	-100.2M	0	8.9M	8.9M	11.5M	11.5M	10.9M	10.9M	11.4M
Goodwill & intangibles	47.6M	41.1M	34.8M	29.1M	23.5M	19.9M	9.4M	9.1M	7.3M	5.6M
Total assets	524.8M	490M	483.8M	488.8M	494M	598.4M	607.5M	596.4M	580.9M	564.9M
Accounts payable	—	—	—	—	—	—	—	—	—	—
Short-term debt	201.5M	181.1M	196.4M	212.9M	236.2M	271.9M	298.1M	326.6M	348.9M	356.2M
Total current liabilities	213.9M	193.8M	208.6M	226.2M	256.4M	284.4M	311.3M	340.6M	360M	370.9M
Long-term debt	114.2M	75.4M	64.9M	69.7M	67.8M	68.4M	56.2M	43.8M	30.3M	29.8M
Total liabilities	333.5M	279.4M	285.1M	307.1M	335M	363.1M	378.4M	395.4M	401.3M	412.5M
Shareholders' equity	191.3M	210.6M	198.6M	181.7M	159M	235.3M	229.1M	200.9M	179.5M	152.4M
Total debt	315.7M	256.4M	261.3M	282.6M	304M	340.3M	354.3M	370.4M	379.2M	386M
Net debt	311.8M	253M	256.2M	276.5M	298.3M	317.8M	346.7M	362.2M	372.1M	379.3M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	8.4M	8.2M	7.7M	5.6M	6.4M	7.1M	7M	6.6M	6.9M	6.7M	7.1M	6.8M
Receivables	14.6M	14.3M	14.9M	14.7M	15.6M	15.1M	15.2M	15.3M	15.7M	15.6M	15.5M	15.5M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	106.3M	105.8M	123M	119.2M	121.2M	105M	120.3M	117.4M	118.7M	104.4M	104.5M	104M
Property, plant & equipment	11M	10.9M	10.9M	10.9M	10.9M	10.9M	10.9M	10.9M	10.9M	11.4M	11.4M	11.4M
Goodwill & intangibles	9.7M	9.1M	8.7M	8.2M	7.8M	7.3M	6.9M	6.5M	6M	5.6M	5.3M	4.9M
Total assets	607.9M	596.4M	596.2M	586.6M	584.3M	580.9M	573.5M	573M	568M	564.9M	563.8M	567.1M
Accounts payable	—	—	—	—	—	—	—	—	—	—	—	—
Short-term debt	321.5M	326.6M	333.6M	342.9M	347.8M	348.9M	349.5M	354.8M	357.1M	356.2M	359.5M	365.6M
Total current liabilities	335.6M	340.6M	344.9M	354.1M	361.2M	360M	360.1M	367.1M	369.2M	370.9M	374M	381.5M
Long-term debt	50.3M	43.8M	43.4M	30.9M	30.6M	30.3M	29.9M	29.6M	29.5M	29.8M	29.7M	29.5M
Total liabilities	397.6M	395.4M	399.7M	395.9M	402.7M	401.3M	401.3M	407.9M	409.5M	412.5M	416M	423.2M
Shareholders' equity	210.3M	200.9M	196.5M	190.7M	181.6M	179.5M	172.2M	165.2M	158.6M	152.4M	147.8M	143.9M
Total debt	371.8M	370.4M	377.1M	373.8M	378.3M	379.2M	379.4M	384.4M	386.5M	386M	389.2M	395.1M
Net debt	363.4M	362.2M	369.4M	368.2M	372M	372.1M	372.5M	377.9M	379.6M	379.3M	382.1M	388.3M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	17.2M	45.6M	24.2M	19M	19.4M	109.2M	21.1M	15.4M	19.2M	17.6M
Depreciation & amortization	23M	25.1M	24.8M	25.7M	25.4M	27.3M	26.4M	27.6M	27.2M	28.7M
Stock-based compensation	481K	538K	571K	702K	912K	947K	780K	780K	853K	936K
Change in working capital	756K	4.5M	-369K	-636K	-1M	-1.8M	-1.4M	215K	187K	669K
Operating cash flow	40.6M	72.8M	43.8M	44.2M	44.5M	135M	45.7M	42.9M	47M	49.1M
Capital expenditure	-60.4M	-9M	-4.1M	-2.3M	-2.3M	15.1M	-13.6M	-3.7M	—	—
Investing cash flow	-70.4M	-12.2M	-1.4M	-4.5M	-5.5M	-10.5M	-15.1M	-4.3M	-5.9M	-6.8M
Dividends paid	-35.1M	-36.1M	-36.8M	-37.4M	-38M	-38.5M	-39.2M	-39.8M	-40.4M	-41M
Share repurchases	—	0	0	-221K	-267K	0	0	—	-131K	—
Financing cash flow	34.1M	-106.5M	-33.3M	-25.1M	-17.4M	-6.5M	-25M	-23.2M	-34.1M	-34.5M
Net change in cash	4.3M	-45.8M	9.2M	14.6M	21.6M	117.9M	5.6M	15.4M	7M	7.7M
Free cash flow	-19.7M	37M	38.9M	37.5M	41.9M	34.7M	33.2M	35.3M	46.9M	49.1M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	3.9M	3.6M	5.3M	5.3M	4M	4.7M	4.8M	4.5M	4M	4.3M	5M	5.9M
Depreciation & amortization	7M	7.2M	6.8M	6.8M	7M	6.8M	6.8M	7M	7.9M	7.1M	6.9M	7M
Stock-based compensation	201K	203K	202K	211K	222K	218K	213K	213K	236K	274K	190K	203K
Change in working capital	-1.8M	431K	447K	59K	-2.4M	2.1M	300K	999K	-2.1M	1.5M	1.2M	1.1M
Operating cash flow	8.7M	11.2M	12.5M	12.1M	8.6M	13.7M	11.7M	12.3M	10.2M	13.6M	11.9M	12.4M
Capital expenditure	-7.6M	3.9M	—	—	—	—	—	—	—	—	—	—
Investing cash flow	-7.8M	3.9M	-6M	0	0	0	-328K	-6.5M	8K	0	-191K	0
Dividends paid	-9.9M	-10M	-10M	-10.2M	-10.1M	-10.2M	-10.2M	-10.3M	-10.2M	-10.3M	-10.3M	-10.5M
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	9.8M	-11.3M	-3.3M	-13.5M	-7.6M	-9.6M	-9.8M	-5.3M	-8.1M	-11.3M	-7.1M	-4.6M
Net change in cash	10.7M	3.8M	3.2M	-1.4M	1M	4.2M	1.6M	538K	2.1M	2.3M	4.6M	7.8M
Free cash flow	2.6M	10.4M	11.7M	12.1M	9.9M	13.2M	11.6M	13.7M	10.2M	13.6M	11.9M	12.4M

Universal Health Realty Income Trust Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement